These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 10464631

  • 21. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
    Ganguly T, Dhulipala R, Godmilow L, Ganguly A.
    Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
    [Abstract] [Full Text] [Related]

  • 22. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.
    Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI, Brower ST, Eng CM.
    Am J Hum Genet; 1998 Jul; 63(1):45-51. PubMed ID: 9634504
    [Abstract] [Full Text] [Related]

  • 23. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ, Linfert DR, Johnson RC, Ackroyd R, Berman MM, Ricci A.
    Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
    [Abstract] [Full Text] [Related]

  • 24. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.
    Cas Lek Cesk; 2000 Oct 11; 139(20):635-7. PubMed ID: 11192759
    [Abstract] [Full Text] [Related]

  • 25. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.
    Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T.
    Am J Hum Genet; 1997 Mar 11; 60(3):505-14. PubMed ID: 9042909
    [Abstract] [Full Text] [Related]

  • 26. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients.
    Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ.
    Gynecol Oncol; 2000 Aug 11; 78(2):148-51. PubMed ID: 10926794
    [Abstract] [Full Text] [Related]

  • 27. Genetic analyses of male breast cancer in Israel.
    Sverdlov RS, Barshack I, Bar Sade RB, Baruch RG, Hirsh-Yehezkel G, Dagan E, Feinmesser M, Figer A, Friedman E.
    Genet Test; 2000 Aug 11; 4(3):313-7. PubMed ID: 11142766
    [Abstract] [Full Text] [Related]

  • 28. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
    Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R, MacDonald DJ, Unsal H, Finkelstein DM, Bowcock A, Isselbacher KJ, Haber DA.
    N Engl J Med; 1997 May 15; 336(20):1416-21. PubMed ID: 9145678
    [Abstract] [Full Text] [Related]

  • 29. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
    Stadler ZK, Saloustros E, Hansen NA, Schluger AE, Kauff ND, Offit K, Robson ME.
    Breast Cancer Res Treat; 2010 Sep 15; 123(2):581-5. PubMed ID: 20221693
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer.
    Rebbeck TR, Rogatko A, Viana MA.
    Genet Test; 2010 Sep 15; 1(3):157-64. PubMed ID: 10464641
    [Abstract] [Full Text] [Related]

  • 31. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E, Zientek H, Jasinska A, Rusin M, Kozlowski P, Sobczak K, Sikorska A, Kwiatkowska E, Gorniak L, Kalinowska E, Utracka-Hutka B, Wloch J, Chmielik E, Krzyzosiak WJ.
    Hum Mutat; 2000 Dec 15; 16(6):482-90. PubMed ID: 11102977
    [Abstract] [Full Text] [Related]

  • 32. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
    Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, Hanna D, Narod SA.
    Hum Mutat; 2002 Nov 15; 20(5):352-7. PubMed ID: 12402332
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
    Díez O, Osorio A, Robledo M, Barroso A, Domènech M, Cortés J, Albertos J, Sanz J, Brunet J, SanRomán JM, Alonso MC, Baiget M, Benítez J.
    Br J Cancer; 1999 Mar 15; 79(7-8):1302-3. PubMed ID: 10098775
    [Abstract] [Full Text] [Related]

  • 34. Mutation testing of early-onset breast cancer genes BRCA1 and BRCA2.
    Neuhausen SL, Ostrander EA.
    Genet Test; 1997 Mar 15; 1(2):75-83. PubMed ID: 10464630
    [Abstract] [Full Text] [Related]

  • 35. Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.
    Ramus SJ, Fishman A, Pharoah PD, Yarkoni S, Altaras M, Ponder BA.
    Eur J Surg Oncol; 2001 Apr 15; 27(3):278-81. PubMed ID: 11373105
    [Abstract] [Full Text] [Related]

  • 36. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N, Kotar K, Foulkes WD.
    BMC Med Genet; 2003 Aug 11; 4():7. PubMed ID: 12911837
    [Abstract] [Full Text] [Related]

  • 37. Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.
    Schorge JO, Mahoney NM, Miller DS, Coleman RL, Muller CY, Euhus DM, Tomlinson GE.
    Gynecol Oncol; 2001 Nov 11; 83(2):383-7. PubMed ID: 11606101
    [Abstract] [Full Text] [Related]

  • 38. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
    Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA.
    Am J Hum Genet; 1999 Apr 11; 64(4):963-70. PubMed ID: 10090881
    [Abstract] [Full Text] [Related]

  • 39. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H.
    Br J Cancer; 2000 Sep 11; 83(6):737-42. PubMed ID: 10952777
    [Abstract] [Full Text] [Related]

  • 40. Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study.
    Drucker L, Stackievitz R, Shpitz B, Yarkoni S.
    Anticancer Res; 2000 Sep 11; 20(1B):559-61. PubMed ID: 10769725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.